What did you do? To get a deeper insight into creating decision trees on the laptop‚ I started to inform myself about possible supporting tools that can be used. As I am using an Apple MacBook‚ I found out that the software “XMind” cannot just help for drawing decision trees‚ but also for developing flowing charts‚ mind maps or to-do-lists. I thought about using Microsoft Excel as a tool for sorting the data. However‚ I finally looked up the necessary information in the given table without using
Premium Decision theory Decision engineering Decision making
Outline A Decision Tree Model and Its Analysis • The following concepts are introduced through the use of a simple decision tree example (the Bill Sampras ’ summer job decision): Decision tree Decision node Event node Mutually exclusive and collectively exhaustive set of events Branches and final values Expected Monetary Value (EMV) Optimal decision strategy • Introduction of the folding back or backward induction procedure for solving a decision tree. • Discussion on sensitivity analysis in a decision
Premium Decision tree Decision theory
How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Management Education Psychology
Merck SWOT Analysis MGT/521 July 25‚ 2012 Merck SWOT Analysis Company Overview Merck is the 2nd largest pharmaceutical company in world offering prescription medications‚ biologics‚ vaccines‚ animal health‚ and consumer care products. It generated 48 billion dollars in revenue in 2011 and has 40‚000 employees. Research and development of proprietary medicines for global marketing is the core of the business. Recent acquisitions and transactions designed to take advantage
Premium Management Strategic management Marketing
Decision Tree Portfolio 1 Decision Tree Portfolio Psy 410 Kathleen McCabe University of Phoenix January 21‚ 2012 Lara Ashbaugh Decision Tree Portfolio 2 The Portfolio for my Decision Tree is concerning a residential fire. The first place that would be called is 911. The dispatchers in our area immediately contact the local and closest fire station(s) to respond. The following takes place after 911 has been called. The 911 dispatchers contact the police and fire departments
Premium Medicine Decision tree Risk
Licensing A licensing agreement is an arrangement whereby a licensor grants the rights to intangible property to another entity (the licensee) for a specified period‚ and in return‚ the licensor receives a royalty fee from the licensee. 15 Intangible properties includes patents‚ inventions‚ formulas‚ processes‚ designs‚ copyrights‚ and trademarks Advantages Disadvantages the firm does not have to bear the development costs and risks associated with opening a foreign market. Licensing is very
Premium License Royalties Franchising
Business and Professional Ethics MERCK AND THE MARKETING OF VIOXX – CASE ANALYSIS Questions 1) What are the highlights of the case? 2) What are the ethical issues in the case? 3) What the ethical theories evidenced in the case? 4) How would you resolve the problem? What are the ethical issues in the case? In identifying the issue(s) we first have to identify the level in which this business is operating. Merck & Company was a top‚ well respected pharmaceutical company in America
Premium Ethics
1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Expected value License Money
As a result of worldwide withdrawal of Vioxx‚ Merck faced a serious public relations crisis in the fall of 2004. Pharmaceutical giant’s officials were forced to defend company’s actions‚ its motivation for those actions‚ and its reputation after several articles‚ negatively reflecting on Merck’s behavior handling the Vioxx case‚ had been published. As an initial response to Vioxx crisis‚ the company released “An Open Letter from Merck” and “For 100 years‚ patients first” in attempt at a positive
Premium Pharmacology Pharmaceutical drug Drug
Merck & Co Case Analysis 1. Problem Statement – Merck & Co ‘s stock market performance had trailed that of competitors in light of the concerns that company was not able to adapt to the changes in environment where as competitors was using their aggressive marketing functional unit as their competitive edge. Company also failed to take advantage of its own market opportunities especially the outcome of aftermarket studies of drugs they launched .Company was very late in adapting to
Premium Organizational structure Marketing Product management